Abstract
Flour prepared from the peels of passion fruit (Passiflora edulis fo. flavicarpa O. Deg.) has been shown to have several health benefits. It has been shown to increase the concentration of high density lipoproteins (HDL) in blood, reduce the concentrations of glucose, cholesterol and LDL, as well as lower blood pressures and body weights in diabetic rats and people. Passion fruit peels are fed to cattle and there have been reports on their increasing milk production and preventing bacterial infections. The peel flour is mostly made of pectin, a dietary fiber. CP-MAS 13C-NMR was used to verify the composition of one sample, which produced chemical shifts (peaks) at 21 and 54 ppm. They were due to OCOCH3 and COOCH3, which are acetyl and methyl ester derivatives of polygalacturonic acid. There were also peaks due to glucuronic acid carbons 1-5 from 65–88 ppm, carbon-1 at 104 ppm and C-6 (carbonyls, acid and ester) at 172 ppm. This may prove to be a good method for verifying the identity of passion fruit peel flour.
Keywords: Passion fruit, diabetes, cancer prevention, CP-MAS NMR, pectin, lesterol, glucose, non-diabetic, flour, low density poproteins
The Natural Products Journal
Title:Potential Health Benefits of Passion Fruit Peel Flour
Volume: 2 Issue: 2
Author(s): Robert E. Smith, Ellen M. da Silva Menezes, Armando U. O. Sabaa-Srur and Wei Wycoff
Affiliation:
Keywords: Passion fruit, diabetes, cancer prevention, CP-MAS NMR, pectin, lesterol, glucose, non-diabetic, flour, low density poproteins
Abstract: Flour prepared from the peels of passion fruit (Passiflora edulis fo. flavicarpa O. Deg.) has been shown to have several health benefits. It has been shown to increase the concentration of high density lipoproteins (HDL) in blood, reduce the concentrations of glucose, cholesterol and LDL, as well as lower blood pressures and body weights in diabetic rats and people. Passion fruit peels are fed to cattle and there have been reports on their increasing milk production and preventing bacterial infections. The peel flour is mostly made of pectin, a dietary fiber. CP-MAS 13C-NMR was used to verify the composition of one sample, which produced chemical shifts (peaks) at 21 and 54 ppm. They were due to OCOCH3 and COOCH3, which are acetyl and methyl ester derivatives of polygalacturonic acid. There were also peaks due to glucuronic acid carbons 1-5 from 65–88 ppm, carbon-1 at 104 ppm and C-6 (carbonyls, acid and ester) at 172 ppm. This may prove to be a good method for verifying the identity of passion fruit peel flour.
Export Options
About this article
Cite this article as:
E. Smith Robert, M. da Silva Menezes Ellen, U. O. Sabaa-Srur Armando and Wycoff Wei, Potential Health Benefits of Passion Fruit Peel Flour, The Natural Products Journal 2012; 2 (2) . https://dx.doi.org/10.2174/2210315511202020104
DOI https://dx.doi.org/10.2174/2210315511202020104 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adult Stem Cell Application in Spinal Cord Injury
Current Drug Targets In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Current Alzheimer Research PET Imaging of Adenosine Receptors in Diseases
Current Topics in Medicinal Chemistry Editorial
Current Medicinal Chemistry GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Perspectives on the Development of Antioxidant Antiepileptogenic Agents
Mini-Reviews in Medicinal Chemistry Lithium in Psychiatry-The Benefits and Risks Associated with the Lithium Salts Treatment in Affective Disorders
Current Psychopharmacology Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study
Central Nervous System Agents in Medicinal Chemistry Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches
Current Pharmaceutical Design The Potential of Caffeine for Functional Modification from Cortical Synapses to Neuron Networks in the Brain
Current Neuropharmacology The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Origin and Expansion of Trinucleotide Repeats and Neurological Disorders
Current Genomics The Glutamatergic Neurotransmission in the Central Nervous System
Current Medicinal Chemistry Histone Acetylation in Neurodevelopment
Current Pharmaceutical Design Synthesis and Antioxidant Activity of Indole Derivatives Containing 4-Substituted Piperazine Moieties
Letters in Drug Design & Discovery